Danish Cancer Institute’s Post

⭐ Scientific Achievements in 2024 ⭐ 🔟 This year, The Cancer Structural Biology (CSB) team achieved a major breakthrough with the first use of a novel structure-based protocol linking genetic variant pathogenicity to cellular mechanisms. This approach focused on lysosomal acid sphingomyelinase (ASM), a crucial enzyme in lipid metabolism linked to genetic disorders and cancer. By integrating molecular dynamics simulations with pathogenicity predictions, the team developed a structural atlas of over 400 ASM variants, validated through experiments on 100+ cases. These findings advance our understanding of ASM-related diseases and open the door to therapies such as enzyme replacement therapy. The article “𝑨𝑺𝑴 𝒗𝒂𝒓𝒊𝒂𝒏𝒕𝒔 𝒊𝒏 𝒕𝒉𝒆 𝒔𝒑𝒐𝒕𝒍𝒊𝒈𝒉𝒕: 𝑨 𝒔𝒕𝒓𝒖𝒄𝒕𝒖𝒓𝒆-𝒃𝒂𝒔𝒆𝒅 𝒂𝒕𝒍𝒂𝒔 𝒇𝒐𝒓 𝒖𝒏𝒓𝒂𝒗𝒆𝒍𝒊𝒏𝒈 𝒑𝒂𝒕𝒉𝒐𝒈𝒆𝒏𝒊𝒄 𝒎𝒆𝒄𝒉𝒂𝒏𝒊𝒔𝒎𝒔 𝒊𝒏 𝒍𝒚𝒔𝒐𝒔𝒐𝒎𝒂𝒍 𝒂𝒄𝒊𝒅 𝒔𝒑𝒉𝒊𝒏𝒈𝒐𝒎𝒚𝒆𝒍𝒊𝒏𝒂𝒔𝒆” was published in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease in October 2024.

To view or add a comment, sign in

Explore topics